Renergen (STU:9960) Tax Provision : €1.47 Mil (TTM As of Aug. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Renergen Tax Provision?

Renergen's tax provision for the six months ended in Aug. 2024 was €0.71 Mil. Its tax provision for the trailing twelve months (TTM) ended in Aug. 2024 was €1.47 Mil.

Renergen Tax Provision Historical Data

The historical data trend for Renergen's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renergen Tax Provision Chart

Renergen Annual Data

Trend

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Feb23

Feb24

Feb25

Tax Provision

Get a 7-Day Free Trial

0.46

0.50

0.51

1.81

Renergen Semi-Annual Data
	Aug16	Feb17	Aug17	Feb18	Aug18	Feb19	Aug19	Feb20	Aug20	Feb21	Aug21	Feb22	Aug22	Feb23	Aug23	Feb24	Aug24
Tax Provision	Get a 7-Day Free Trial												0.32	0.22	1.06	0.76	0.71

Renergen Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Aug. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €1.47 Mil.

Renergen Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Energy » Oil & Gas » Renergen Ltd (STU:9960) » Definitions » Tax Provision

Comparable Companies

Traded in Other Exchanges

REN:South Africa RGNNF:USA RLT:Australia

Address

25 Minerva Avenue, Sandton Gate, Glenadrienne, Sandton, ZAF, 2196

Website

https://www.renergen.co.za

Renergen Ltd is an investment holding company focused on the alternative and renewable energy sectors in South Africa and sub-Saharan Africa. Its reportable segments are the Corporate Head office where all investment decisions are made; Tetra4 which explores, produces, and sells LNG in South Africa; Cryovation which has developed Cryo-VaccTM technology, and enables the safe transportation of vaccines and biologics at extremely low temperatures without the need for electrical power; and the Renergen U.S segment which assists with various fundraising and business development activities of the Group in the U.S market. The majority of the company's revenue is generated from the Tetra4 segment.

Renergen Headlines

No Headlines